SRDK BIOCHEMICALS

Innovating Polymers For Better Therapies

Engineering next-generation polymer platforms for safer, more effective patient-centric therapies

CORE PRODUCTS

Bioabsorbable Polymers For Drug Delivery & 3D Bioprinting

16+ years expertise • Pharmaceutical-grade

PLGA PEG-PLGA PEG Block Copolymers PEG Diacrylates PEG Dimethacrylates
QUALITY ASSURANCE

Pharmaceutical-Grade Specialty Polymers

FDA-relevant materials for biomedical applications and controlled release systems

ADVANCED SOLUTIONS

Advanced Polymers For 3D Bioprinting & Regenerative Medicine

PEG Diacrylates • PEG Dimethacrylates • Photoinitiators for Hydrogels

About SRDK Biochemicals

We specialize in FDA-relevant bioabsorbable polymers for drug delivery, 3D bioprinting, and biomedical applications. With over 16 years of expertise in sustained release formulations, we deliver pharmaceutical-grade polymer solutions that power next-generation therapies.


With over 16 years of expertise in sustained release formulations
With over 16 years of expertise in polymers for sustained release formulations
CIN: U24299KA2021PTC151176
Learn More →
SRDK Biochemicals Lab Facility
16+ Years of Expertise

Our Product Portfolio

Pharmaceutical-grade polymers for advanced therapeutic applications

PEG Diacrylates

PEGDA
  • Photocurable hydrogels
  • 3D bioprinting scaffolds
  • Tissue engineering

PEG Dimethacrylates

PEGDMA
  • Crosslinkable polymers
  • Durable hydrogels
  • Controlled release systems

Photoinitiators

FOR HYDROGELS
  • High-efficiency initiation
  • Rapid curing systems
  • PEGDA/PEGDMA optimized

PLGA

BIOABSORBABLE POLYMERS
  • Biodegradable formulations
  • Long-acting injectables
  • Implant applications

PEG-PLGA

BLOCK COPOLYMERS
  • Amphiphilic properties
  • Micelles & nanoparticles
  • Enhanced drug delivery

PEG Block Copolymers

SPECIALTY POLYMERS
  • Tailored MW control
  • Self-assembly capabilities
  • Controlled release profiles

Quality Assurance

Pharmaceutical-Grade Excellence

GMP-Compliant Manufacturing

  • Stringent quality control
  • Batch consistency
  • Comprehensive testing

Regulatory Readiness

  • FDA-relevant standards
  • Client filing support
  • Full documentation

Advanced Analytical Capabilities

  • GPC / NMR analysis
  • HPLC / Degradation studies
  • Purity confirmation

What We Do

Functional polymers for controlled drug delivery & 3D bioprinting

Drug Delivery Polymers

  • PLGA
  • PEG-PLGA
  • PEG Block Copolymers

3D Bioprinting Polymers

  • PEGDA
  • PEGDMA
  • Photoinitiators

Specialty Polymers

  • Poly(2-oxazoline) (POZ)-Based Polymers
  • Hyaluronic Acid (HA)-Based Polymers
  • GELMA & collagen methacrylate platforms

Applications & Partnerships

  • Long-acting injectables
  • Implants & tissue models
  • Regenerative medicine
  • CDMO partnerships

Our Polymerization Expertise

SRDK Biochemicals offers comprehensive expertise in advanced polymerization techniques, specializing in controlled synthesis of biodegradable and functional polymers for drug delivery and biomedical applications.

Free Radical Polymerization

Conventional Chain-Growth Polymerization
  • High molecular weight polymers
  • Rapid polymerization rates
  • Scalable and cost-effective
  • Wide monomer compatibility
  • Industrial-scale production capability

ATRP

Atom Transfer Radical Polymerization
  • Precise molecular weight control
  • Low dispersity (Đ < 1.3)
  • Complex block copolymer architectures
  • Functional polymer bioconjugates
  • Drug delivery system design

RAFT

Reversible Addition-Fragmentation Chain Transfer
  • Exceptional architectural control
  • Broad monomer compatibility
  • Star and hyperbranched polymers
  • Environmentally friendly process
  • Superior scalability for production

ROP

Ring-Opening Polymerization
  • Biodegradable polymer synthesis
  • PLGA, PCL, PEG copolymers
  • GMP-grade pharmaceutical polymers
  • Controlled molecular architecture
  • Functional aliphatic polyesters

Condensation Polymerization

Step-Growth Polymerization
  • Polyesters and polyamides
  • High thermal stability
  • Precise stoichiometric control
  • Functionalized polymer backbones
  • Pharmaceutical-grade synthesis

Anionic Polymerization

Living Anionic Chain Polymerization
  • Ultra-narrow molecular weight distribution
  • Precise chain-end functionality
  • Well-defined block copolymers
  • High purity product synthesis
  • Controlled polymer architecture